-
1
-
-
84864275588
-
Arterial and venous thrombosis in adults
-
Kottke-Marchant K, ed, 1st ed. Northfield, IL: College of American Pathologists
-
Olson JD, Eby C. Arterial and venous thrombosis in adults. In: Kottke-Marchant K, ed. An algorithmic approach to hemostasis testing. 1st ed. Northfield, IL: College of American Pathologists, 2008:239-66.
-
(2008)
An algorithmic approach to hemostasis testing
, pp. 239-266
-
-
Olson, J.D.1
Eby, C.2
-
2
-
-
79251615145
-
Diagnostic algorithm for thrombophilia screening
-
Margetic S. Diagnostic algorithm for thrombophilia screening. Clin Chem Lab Med 2010;48(Suppl 1):S27-39.
-
(2010)
Clin Chem Lab Med
, vol.48
, Issue.SUPPL. 1
-
-
Margetic, S.1
-
3
-
-
0028108947
-
Laboratory diagnosis of hemorrhagic and thrombotic disorders
-
Kottke-Marchant K. Laboratory diagnosis of hemorrhagic and thrombotic disorders. Hematol Oncol Clin North Am 1994;8:809-53.
-
(1994)
Hematol Oncol Clin North Am
, vol.8
, pp. 809-853
-
-
Kottke-Marchant, K.1
-
4
-
-
68249151034
-
Laboratory evaluation of hypercoagulability
-
Khor B, Van Cott EM. Laboratory evaluation of hypercoagulability. Clin Lab Med 2009;29:339-66.
-
(2009)
Clin Lab Med
, vol.29
, pp. 339-366
-
-
Khor, B.1
Van Cott, E.M.2
-
5
-
-
48549098855
-
Thrombophilia: common questions on laboratory assessment and management
-
Heit JA. Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program 2007:127-35.
-
(2007)
Hematology Am Soc Hematol Educ Program
, pp. 127-135
-
-
Heit, J.A.1
-
6
-
-
77949821581
-
Clinical guidelines for testing for heritable thrombophilia
-
Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 2010;149:209-20.
-
(2010)
Br J Haematol
, vol.149
, pp. 209-220
-
-
Baglin, T.1
Gray, E.2
Greaves, M.3
-
7
-
-
84864273146
-
Laboratory diagnosis of inherited thrombophilia
-
Kottke-Marchant K, ed, 1st ed. Northfield, IL: College of American Pathologists
-
Eby C. Laboratory diagnosis of inherited thrombophilia. In: Kottke-Marchant K, ed. An algorithmic approach to hemostasis testing. 1st ed. Northfield, IL: College of American Pathologists, 2008:267-77.
-
(2008)
An algorithmic approach to hemostasis testing
, pp. 267-277
-
-
Eby, C.1
-
8
-
-
79958093890
-
Evidence-based approach to thrombophilia testing
-
Middeldorp S. Evidence-based approach to thrombophilia testing. J Thromb Thrombolysis 2011;31:275-81.
-
(2011)
J Thromb Thrombolysis
, vol.31
, pp. 275-281
-
-
Middeldorp, S.1
-
9
-
-
67149126682
-
Antiphospholipid antibodies
-
Kottke-Marchant K, ed, 1st ed. Northfield, IL: College of American Pathologists
-
Van Cott EM, Eby C. Antiphospholipid antibodies. In: Kottke-Marchant K, ed. An algorithmic approach to hemostasis testing. 1st ed. Northfield, IL: College of American Pathologists, 2008:295-304.
-
(2008)
An algorithmic approach to hemostasis testing
, pp. 295-304
-
-
Van Cott, E.M.1
Eby, C.2
-
10
-
-
33344458573
-
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
-
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4: 295-306.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, T.3
-
11
-
-
70350004861
-
Update of the guidelines for lupus anticoagulant detection
-
Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009;7:1737-40.
-
(2009)
J Thromb Haemost
, vol.7
, pp. 1737-1740
-
-
Pengo, V.1
Tripodi, A.2
Reber, G.3
-
12
-
-
0029953246
-
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
-
Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 1996;100:530-6.
-
(1996)
Am J Med
, vol.100
, pp. 530-536
-
-
Finazzi, G.1
Brancaccio, V.2
Moia, M.3
-
13
-
-
0028810205
-
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH
-
Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185-90.
-
(1995)
Thromb Haemost
, vol.74
, pp. 1185-1190
-
-
Brandt, J.T.1
Triplett, D.A.2
Alving, B.3
Scharrer, I.4
-
14
-
-
7044236943
-
Anti-beta2-glycoprotein I antibodieswhen and how should they be measured?
-
Reber G, de Moerloose P. Anti-beta2-glycoprotein I antibodieswhen and how should they be measured? Thromb Res 2004;114: 527-31.
-
(2004)
Thromb Res
, vol.114
, pp. 527-531
-
-
Reber, G.1
de Moerloose, P.2
-
15
-
-
84885733441
-
Lupus anticoagulants, antiphospholipid antibodies, and antiphospholipid syndrome
-
Kottke-Marchant K, Davis BH, eds, West Sussex, UK: Wiley-Blackwell Publishing ltd
-
Nichols WL, Kottke-Marchant K, Ledford-Kraemer MR, Homburger HA, Cardel LK. Lupus anticoagulants, antiphospholipid antibodies, and antiphospholipid syndrome. In: Kottke-Marchant K, Davis BH, eds. Laboratory hematology practice. West Sussex, UK: Wiley-Blackwell Publishing ltd, 2012:509-25.
-
(2012)
Laboratory hematology practice
, pp. 509-525
-
-
Nichols, W.L.1
Kottke-Marchant, K.2
Ledford-Kraemer, M.R.3
Homburger, H.A.4
Cardel, L.K.5
-
16
-
-
84858283382
-
Guidelines on the investigation and management of antiphospholipid syndrome
-
Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012;157:47-58.
-
(2012)
Br J Haematol
, vol.157
, pp. 47-58
-
-
Keeling, D.1
Mackie, I.2
Moore, G.W.3
Greer, I.A.4
Greaves, M.5
-
17
-
-
84903533351
-
Laboratory testing for the lupus anticoagulant; Approved guideline
-
CLSI document H60. Wayne, PA: Clinical and Laboratory Standards Institute
-
Ledford-Kraemer MR, Moore GW, Bottenus R, et al, eds. Laboratory testing for the lupus anticoagulant; Approved guideline. CLSI document H60. Wayne, PA: Clinical and Laboratory Standards Institute, 2014.
-
(2014)
-
-
Ledford-Kraemer, M.R.1
Moore, G.W.2
Bottenus, R.3
-
18
-
-
84885712760
-
Thrombophilia: assays and interpretation
-
Kottke-Marchant K, Davis BH, eds, West Sussex, UK: Wiley-Blackwell Publishing ltd
-
Yohe S, Olson J. Thrombophilia: assays and interpretation. In: Kottke-Marchant K, Davis BH, eds. Laboratory hematology practice. West Sussex, UK: Wiley-Blackwell Publishing ltd, 2012:492-508.
-
(2012)
Laboratory hematology practice
, pp. 492-508
-
-
Yohe, S.1
Olson, J.2
-
19
-
-
60849125416
-
Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices
-
Moffat KA, Ledford-Kraemer MR, Plumhoff EA, et al. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices. Thromb Haemost 2009;101:178-84.
-
(2009)
Thromb Haemost
, vol.101
, pp. 178-184
-
-
Moffat, K.A.1
Ledford-Kraemer, M.R.2
Plumhoff, E.A.3
-
20
-
-
0036881080
-
Antiphospholipid antibodies
-
Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002;126:1424-9.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 1424-1429
-
-
Triplett, D.A.1
-
21
-
-
0141958839
-
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
-
Galli M, Luciani D, Bertolini G, Barbui T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003;102:2717-23.
-
(2003)
Blood
, vol.102
, pp. 2717-2723
-
-
Galli, M.1
Luciani, D.2
Bertolini, G.3
Barbui, T.4
-
22
-
-
0345689340
-
Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome
-
Marai I, Gilburd B, Blank M, Shoenfeld Y. Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome. Hum Antibodies 2003;12: 57-62.
-
(2003)
Hum Antibodies
, vol.12
, pp. 57-62
-
-
Marai, I.1
Gilburd, B.2
Blank, M.3
Shoenfeld, Y.4
-
23
-
-
0028931717
-
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
-
Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995;85:1504-8.
-
(1995)
Blood
, vol.85
, pp. 1504-1508
-
-
Rosendaal, F.R.1
Koster, T.2
Vandenbroucke, J.P.3
Reitsma, P.H.4
-
24
-
-
0031023757
-
A single genetic origin for a common Caucasian risk factor for venous thrombosis
-
Zivelin A, Griffin JH, Xu X, et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997;89:397-402.
-
(1997)
Blood
, vol.89
, pp. 397-402
-
-
Zivelin, A.1
Griffin, J.H.2
Xu, X.3
-
25
-
-
0030955080
-
Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening
-
Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997;277:1305-7.
-
(1997)
JAMA
, vol.277
, pp. 1305-1307
-
-
Ridker, P.M.1
Miletich, J.P.2
Hennekens, C.H.3
Buring, J.E.4
-
26
-
-
0028352460
-
Activated protein C resistance caused by Arg506Gln mutation in factor Va
-
Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994;343:1361-2.
-
(1994)
Lancet
, vol.343
, pp. 1361-1362
-
-
Greengard, J.S.1
Sun, X.2
Xu, X.3
Fernandez, J.A.4
Griffin, J.H.5
Evatt, B.6
-
27
-
-
0032520034
-
A novel mutation of Arg306 of factor V gene in Hong Kong Chinese
-
Chan WP, Lee CK, Kwong YL, Lam CK, Liang R. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 1998; 91:1135-9.
-
(1998)
Blood
, vol.91
, pp. 1135-1139
-
-
Chan, W.P.1
Lee, C.K.2
Kwong, Y.L.3
Lam, C.K.4
Liang, R.5
-
28
-
-
0033038853
-
The prevalence of factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in different human populations
-
Franco RF, Elion J, Tavella MH, Santos SE, Zago MA. The prevalence of factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in different human populations. Thromb Haemost 1999;81:312-3.
-
(1999)
Thromb Haemost
, vol.81
, pp. 312-313
-
-
Franco, R.F.1
Elion, J.2
Tavella, M.H.3
Santos, S.E.4
Zago, M.A.5
-
29
-
-
0037100417
-
Functional characterization of recombinant FV Hong Kong and FV Cambridge
-
Norstrom E, Thorelli E, Dahlback B. Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood 2002;100:524-30.
-
(2002)
Blood
, vol.100
, pp. 524-530
-
-
Norstrom, E.1
Thorelli, E.2
Dahlback, B.3
-
30
-
-
0036881044
-
Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders
-
Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 2002;126:1304-18.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 1304-1318
-
-
Press, R.D.1
Bauer, K.A.2
Kujovich, J.L.3
Heit, J.A.4
-
31
-
-
0034189760
-
A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay
-
Ledford M, Friedman KD, Hessner MJ, Moehlenkamp C, Williams TM, Larson RS. A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay. J Mol Diagn 2000;2:97-104.
-
(2000)
J Mol Diagn
, vol.2
, pp. 97-104
-
-
Ledford, M.1
Friedman, K.D.2
Hessner, M.J.3
Moehlenkamp, C.4
Williams, T.M.5
Larson, R.S.6
-
32
-
-
84885766496
-
Single nucleotide polymorphisms in molecular diagnostics
-
Kottke-Marchant K, Davis BH, eds, West Sussex, UK: Wiley-Blackwell Publishing ltd
-
Murugesan G, Jans S, Han JY. Single nucleotide polymorphisms in molecular diagnostics. In: Kottke-Marchant K, Davis BH, eds. Laboratory hematology practice. West Sussex, UK: Wiley-Blackwell Publishing ltd, 2012:168-80.
-
(2012)
Laboratory hematology practice
, pp. 168-180
-
-
Murugesan, G.1
Jans, S.2
Han, J.Y.3
-
33
-
-
0036881490
-
Clinical and laboratory management of the prothrombin G20210A mutation
-
McGlennen RC, Key NS. Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med 2002;126:1319-25.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 1319-1325
-
-
McGlennen, R.C.1
Key, N.S.2
-
34
-
-
0031981017
-
Geographic distribution of the 20210 G to A prothrombin variant
-
Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-8.
-
(1998)
Thromb Haemost
, vol.79
, pp. 706-708
-
-
Rosendaal, F.R.1
Doggen, C.J.2
Zivelin, A.3
-
35
-
-
84860625977
-
Pathology consultation on the laboratory evaluation of thrombophilia: when, how, and why
-
Ballard RB, Marques MB. Pathology consultation on the laboratory evaluation of thrombophilia: when, how, and why. Am J Clin Pathol 2012;137:553-60.
-
(2012)
Am J Clin Pathol
, vol.137
, pp. 553-560
-
-
Ballard, R.B.1
Marques, M.B.2
-
36
-
-
0029850530
-
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
-
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
-
(1996)
Blood
, vol.88
, pp. 3698-3703
-
-
Poort, S.R.1
Rosendaal, F.R.2
Reitsma, P.H.3
Bertina, R.M.4
-
37
-
-
77953077082
-
Laboratory tests for protein C deficiency
-
Khor B, Van Cott EM. Laboratory tests for protein C deficiency. Am J Hematol 2010;85:440-2.
-
(2010)
Am J Hematol
, vol.85
, pp. 440-442
-
-
Khor, B.1
Van Cott, E.M.2
-
38
-
-
0036881556
-
Laboratory evaluation of hypercoagulability with venous or arterial thrombosis
-
Van Cott EM, Laposata M, Prins MH. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch Pathol Lab Med 2002;126:1281-95.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 1281-1295
-
-
Van Cott, E.M.1
Laposata, M.2
Prins, M.H.3
-
39
-
-
42449084553
-
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
-
Maurissen LF, Thomassen MC, Nicolaes GA, et al. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood 2008;111:3034-41.
-
(2008)
Blood
, vol.111
, pp. 3034-3041
-
-
Maurissen, L.F.1
Thomassen, M.C.2
Nicolaes, G.A.3
-
40
-
-
48449101323
-
Protein S is a cofactor for tissue factor pathway inhibitor
-
Rosing J, Maurissen LF, Tchaikovski SN, Tans G, Hackeng TM. Protein S is a cofactor for tissue factor pathway inhibitor. Thromb Res 2008;122:S60-3.
-
(2008)
Thromb Res
, vol.122
-
-
Rosing, J.1
Maurissen, L.F.2
Tchaikovski, S.N.3
Tans, G.4
Hackeng, T.M.5
-
41
-
-
0034994094
-
A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state
-
Dykes AC, Walker ID, McMahon AD, Islam SI, Tait RC. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001;113:636-41.
-
(2001)
Br J Haematol
, vol.113
, pp. 636-641
-
-
Dykes, A.C.1
Walker, I.D.2
McMahon, A.D.3
Islam, S.I.4
Tait, R.C.5
-
42
-
-
0030001877
-
New direct assay of free protein S antigen applied to diagnosis of protein S deficiency
-
Aillaud MF, Pouymayou K, Brunet D, et al. New direct assay of free protein S antigen applied to diagnosis of protein S deficiency. Thromb Haemost 1996;75:283-5.
-
(1996)
Thromb Haemost
, vol.75
, pp. 283-285
-
-
Aillaud, M.F.1
Pouymayou, K.2
Brunet, D.3
-
43
-
-
55249124089
-
Regulation of coagulation by protein S
-
Castoldi E, Hackeng TM. Regulation of coagulation by protein S. Curr Opin Hematol 2008;15:529-36.
-
(2008)
Curr Opin Hematol
, vol.15
, pp. 529-536
-
-
Castoldi, E.1
Hackeng, T.M.2
-
44
-
-
46749102183
-
PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations
-
Ten Kate MK, Platteel M, Mulder R, et al. PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations. Hum Mutat 2008;29: 939-47.
-
(2008)
Hum Mutat
, vol.29
, pp. 939-947
-
-
Ten Kate, M.K.1
Platteel, M.2
Mulder, R.3
-
45
-
-
84872265901
-
Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis
-
Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol 2013;35:1-13.
-
(2013)
Int J Lab Hematol
, vol.35
, pp. 1-13
-
-
Mackie, I.1
Cooper, P.2
Lawrie, A.3
Kitchen, S.4
Gray, E.5
Laffan, M.6
-
46
-
-
19944433631
-
Familial thrombophilia and lifetime risk of venous thrombosis
-
Vossen CY, Conard J, Fontcuberta J, et al. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost 2004;2:1526-32.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1526-1532
-
-
Vossen, C.Y.1
Conard, J.2
Fontcuberta, J.3
-
47
-
-
84903517492
-
Antithrombin deficiency
-
Gulati G, Filicko-O'Hara J, Krause JR, eds, Chicago, IL: American Society for Clinical Pathology Press
-
Rogers HJ, Kottke-Marchant K. Antithrombin deficiency. In: Gulati G, Filicko-O'Hara J, Krause JR, eds. Case studies in hematology and coagulation. Chicago, IL: American Society for Clinical Pathology Press, 2012:416-8.
-
(2012)
Case studies in hematology and coagulation
, pp. 416-418
-
-
Rogers, H.J.1
Kottke-Marchant, K.2
-
48
-
-
0036881507
-
Antithrombin deficiency: issues in laboratory diagnosis
-
Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med 2002;126:1326-36.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 1326-1336
-
-
Kottke-Marchant, K.1
Duncan, A.2
-
49
-
-
33745289474
-
Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene
-
Picard V, Nowak-Gottl U, Biron-Andreani C, et al. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene. Hum Mutat 2006;27:600.
-
(2006)
Hum Mutat
, vol.27
, pp. 600
-
-
Picard, V.1
Nowak-Gottl, U.2
Biron-Andreani, C.3
-
50
-
-
78649524580
-
Laboratory tests for antithrombin deficiency
-
Khor B, Van Cott EM. Laboratory tests for antithrombin deficiency. Am J Hematol 2010;85:947-50.
-
(2010)
Am J Hematol
, vol.85
, pp. 947-950
-
-
Khor, B.1
Van Cott, E.M.2
-
53
-
-
34250333053
-
Hyperhomocysteinemia and thrombosis: an overview
-
Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med 2007;131:872-84.
-
(2007)
Arch Pathol Lab Med
, vol.131
, pp. 872-884
-
-
Eldibany, M.M.1
Caprini, J.A.2
-
54
-
-
0037633079
-
Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies
-
Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies. Pathophysiol Haemost Thromb 2002;32:51-8.
-
(2002)
Pathophysiol Haemost Thromb
, vol.32
, pp. 51-58
-
-
Ray, J.G.1
Shmorgun, D.2
Chan, W.S.3
-
55
-
-
20444445722
-
Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies
-
Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005;3:292-9.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 292-299
-
-
Den Heijer, M.1
Lewington, S.2
Clarke, R.3
-
56
-
-
84873540085
-
ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing
-
Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med 2013;15:153-6.
-
(2013)
Genet Med
, vol.15
, pp. 153-156
-
-
Hickey, S.E.1
Curry, C.J.2
Toriello, H.V.3
-
57
-
-
0033965871
-
Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response
-
O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 2000;83:10-3.
-
(2000)
Thromb Haemost
, vol.83
, pp. 10-13
-
-
O'Donnell, J.1
Mumford, A.D.2
Manning, R.A.3
Laffan, M.4
-
58
-
-
0038373832
-
High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly
-
Oger E, Lacut K, Van Dreden P, et al. High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly. Haematologica 2003;88:465-9.
-
(2003)
Haematologica
, vol.88
, pp. 465-469
-
-
Oger, E.1
Lacut, K.2
Van Dreden, P.3
-
59
-
-
79957724437
-
High plasma level of factor VIII: an important risk factor for venous thromboembolism
-
Ota S, Yamada N, Ogihara Y, et al. High plasma level of factor VIII: an important risk factor for venous thromboembolism. Circ J 2011;75:1472-5.
-
(2011)
Circ J
, vol.75
, pp. 1472-1475
-
-
Ota, S.1
Yamada, N.2
Ogihara, Y.3
-
61
-
-
0033983988
-
High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism
-
Kraaijenhagen RA, in't Anker PS, Koopman MM, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000;83:5-9.
-
(2000)
Thromb Haemost
, vol.83
, pp. 5-9
-
-
Kraaijenhagen, R.A.1
In't Anker, P.S.2
Koopman, M.M.3
-
62
-
-
0034680013
-
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
-
Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000;343:457-62.
-
(2000)
N Engl J Med
, vol.343
, pp. 457-462
-
-
Kyrle, P.A.1
Minar, E.2
Hirschl, M.3
-
63
-
-
0038141763
-
High levels of factor VIIIc and risk of venous thrombosis: critical analysis of case-control studies
-
Benjaber K, Constans J, Cougnard A, Salmi LR. High levels of factor VIIIc and risk of venous thrombosis: critical analysis of case-control studies. Rev Med Interne 2003;24:366-71.
-
(2003)
Rev Med Interne
, vol.24
, pp. 366-371
-
-
Benjaber, K.1
Constans, J.2
Cougnard, A.3
Salmi, L.R.4
-
64
-
-
0028877613
-
Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen
-
Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995;73:151-61.
-
(1995)
Thromb Haemost
, vol.73
, pp. 151-161
-
-
Haverkate, F.1
Samama, M.2
-
66
-
-
0036880584
-
Dysfibrinogenemia and thrombosis
-
Hayes T. Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med 2002;126:1387-90.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 1387-1390
-
-
Hayes, T.1
-
68
-
-
84881474743
-
Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitations
-
Mani H, Kasper A, Lindhoff-Last E. Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitations. J Thromb Thrombolysis 2013;36:187-94.
-
(2013)
J Thromb Thrombolysis
, vol.36
, pp. 187-194
-
-
Mani, H.1
Kasper, A.2
Lindhoff-Last, E.3
-
69
-
-
84876459325
-
Novel anticoagulants and laboratory testing
-
Eby C. Novel anticoagulants and laboratory testing. Int J Lab Hematol 2013;35:262-8.
-
(2013)
Int J Lab Hematol
, vol.35
, pp. 262-268
-
-
Eby, C.1
-
70
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
-
71
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92.
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
-
72
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91.
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
-
73
-
-
84878260361
-
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
-
Steiner T, Bohm M, Dichgans M, et al. Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol 2013;102:399-412.
-
(2013)
Clin Res Cardiol
, vol.102
, pp. 399-412
-
-
Steiner, T.1
Bohm, M.2
Dichgans, M.3
-
74
-
-
84876192857
-
Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis
-
Baglin T, Hillarp A, Tripodi A, Elalamy I, Buller H, Ageno W. Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2013;11:756-60.
-
(2013)
J Thromb Haemost
, vol.11
, pp. 756-760
-
-
Baglin, T.1
Hillarp, A.2
Tripodi, A.3
Elalamy, I.4
Buller, H.5
Ageno, W.6
-
75
-
-
84862146631
-
Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban
-
Harenberg J, Marx S, Weiss C, Kramer R, Samama M, Schulman S. Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban. J Thromb Haemost 2012;10:1433-6.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 1433-1436
-
-
Harenberg, J.1
Marx, S.2
Weiss, C.3
Kramer, R.4
Samama, M.5
Schulman, S.6
-
76
-
-
84901191606
-
Report of the Subcommittee on Control of Anticoagulation on the determination of the anticoagulant effects of apixaban: communication from the SSC of the ISTH
-
Harenberg J, Du S, Weiss C, Kramer R, Hoppensteadt D, Walenga J. Report of the Subcommittee on Control of Anticoagulation on the determination of the anticoagulant effects of apixaban: communication from the SSC of the ISTH. J Thromb Haemost 2014;12:801-4.
-
(2014)
J Thromb Haemost
, vol.12
, pp. 801-804
-
-
Harenberg, J.1
Du, S.2
Weiss, C.3
Kramer, R.4
Hoppensteadt, D.5
Walenga, J.6
-
77
-
-
84898678739
-
Interpretation of coagulation test results under direct oral anticoagulants
-
Mani H. Interpretation of coagulation test results under direct oral anticoagulants. Int J Lab Hematol 2014;36:261-8.
-
(2014)
Int J Lab Hematol
, vol.36
, pp. 261-268
-
-
Mani, H.1
-
78
-
-
10844233894
-
The ecarin clotting time, a universal method to quantify direct thrombin inhibitors
-
Nowak G. The ecarin clotting time, a universal method to quantify direct thrombin inhibitors. Pathophysiol Haemost Thromb 2003;33:173-83.
-
(2003)
Pathophysiol Haemost Thromb
, vol.33
, pp. 173-183
-
-
Nowak, G.1
|